Literature DB >> 17479265

Are there adaptive changes in the human brain of patients with Parkinson's disease treated with long-term deep brain stimulation of the subthalamic nucleus? A 4-year follow-up study with regional cerebral blood flow SPECT.

Stelvio Sestini1, Alberto Pupi, Franco Ammannati, Ramat Silvia, Sandro Sorbi, Antonio Castagnoli.   

Abstract

PURPOSE: The aim of this follow-up study was to assess persistent motor and regional cerebral blood flow (rCBF) changes in patients with Parkinson's disease (PD) treated with high-frequency deep brain stimulation (DBS) of the subthalamic nucleus (STN).
METHODS: Ten PD patients with STN-DBS underwent three rCBF SPECT studies at rest, once preoperatively in the off-drug condition (T(0)), and twice postoperatively in the off-drug/off-stimulation conditions at 5 +/- 2 (T(1)) and 42 +/- 7 months (T(2)). Patients were assessed using the UPDRS, H&Y and S&E scales. SPM was used to investigate baseline rCBF changes from the preoperative condition to the postoperative conditions and the relationship between rCBF and UPDRS scores used as covariate of interest.
RESULTS: Parkinsonian patients showed a clinical improvement which was significant only on follow-up at 42 months. The main effect of treatment from T(0) to T(1) was to produce baseline rCBF increases in the pre-supplementary motor area (pre-SMA), premotor cortex and somatosensory association cortex. From T(1) to T(2) a further baseline rCBF increase was detected in the pre-SMA (p < 0.0001). A correlation was detected between the slight improvement in motor scores and the rCBF increase in the pre-SMA (p < 0.0001), which is known to play a crucial role in clinical progression.
CONCLUSION: Our study suggests the presence of adaptive functional changes in the human brain of PD patients treated with long-term STN-DBS. Such adaptive processes seem to occur in the pre-SMA and to play only a slightly beneficial role in terms of functional compensation of motor impairment.

Entities:  

Mesh:

Year:  2007        PMID: 17479265     DOI: 10.1007/s00259-007-0428-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  36 in total

1.  No tissue damage by chronic deep brain stimulation in Parkinson's disease.

Authors:  C Haberler; F Alesch; P R Mazal; P Pilz; K Jellinger; M M Pinter; J A Hainfellner; H Budka
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

2.  Synaptic proliferation in the motor cortex of adult cats after long-term thalamic stimulation.

Authors:  A Keller; K Arissian; H Asanuma
Journal:  J Neurophysiol       Date:  1992-07       Impact factor: 2.714

3.  Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus.

Authors:  Karen Østergaard; Niels Aa Sunde
Journal:  Mov Disord       Date:  2006-05       Impact factor: 10.338

4.  Mechanisms of deafferentation-induced plasticity in human motor cortex.

Authors:  U Ziemann; M Hallett; L G Cohen
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

Review 5.  Parkinson's disease. Second of two parts.

Authors:  A E Lang; A M Lozano
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245

6.  Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease.

Authors:  P Limousin; J Greene; P Pollak; J Rothwell; A L Benabid; R Frackowiak
Journal:  Ann Neurol       Date:  1997-09       Impact factor: 10.422

7.  Stimulation of subthalamic nucleus inhibits emotional activation of fusiform gyrus.

Authors:  Jacob Geday; Karen Ostergaard; Albert Gjedde
Journal:  Neuroimage       Date:  2006-09-07       Impact factor: 6.556

Review 8.  Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease.

Authors:  M C Rodriguez-Oroz; A Gorospe; J Guridi; E Ramos; G Linazasoro; M Rodriguez-Palmero; J A Obeso
Journal:  Neurology       Date:  2000       Impact factor: 9.910

9.  Dopamine transporter imaging and the effects of deep brain stimulation in patients with Parkinson's disease.

Authors:  A Lokkegaard; L M Werdelin; L Regeur; M Karlsborg; S R Jensen; E Brødsgaard; F F Madsen; M N Lonsdale; L Friberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-10       Impact factor: 9.236

10.  Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons.

Authors:  Satoshi Maesawa; Yoshiki Kaneoke; Yasukazu Kajita; Naotaka Usui; Nobuaki Misawa; Atsuo Nakayama; Jun Yoshida
Journal:  J Neurosurg       Date:  2004-04       Impact factor: 5.115

View more
  5 in total

Review 1.  Network effects of deep brain stimulation.

Authors:  Ahmad Alhourani; Michael M McDowell; Michael J Randazzo; Thomas A Wozny; Efstathios D Kondylis; Witold J Lipski; Sarah Beck; Jordan F Karp; Avniel S Ghuman; R Mark Richardson
Journal:  J Neurophysiol       Date:  2015-08-12       Impact factor: 2.714

Review 2.  Neural circuit modulation during deep brain stimulation at the subthalamic nucleus for Parkinson's disease: what have we learned from neuroimaging studies?

Authors:  Daniel L Albaugh; Yen-Yu Ian Shih
Journal:  Brain Connect       Date:  2013-12-18

Review 3.  Evidence of Neuroplastic Changes after Transcranial Magnetic, Electric, and Deep Brain Stimulation.

Authors:  Julius Kricheldorff; Katharina Göke; Maximilian Kiebs; Florian H Kasten; Christoph S Herrmann; Karsten Witt; Rene Hurlemann
Journal:  Brain Sci       Date:  2022-07-15

4.  Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon.

Authors:  Clemence Simonin; M Tir; D Devos; A Kreisler; K Dujardin; J Salleron; A Delval; S Blond; L Defebvre; A Destée; P Krystkowiak
Journal:  J Neurol       Date:  2009-06-18       Impact factor: 4.849

5.  Predictive potential of pre-operative functional neuroimaging in patients treated with subthalamic stimulation.

Authors:  Stelvio Sestini; Alberto Pupi; Franco Ammannati; Silvia Ramat; Sandro Sorbi; Roberto Sciagrà; Luigi Mansi; Antonio Castagnoli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.